Citius pharmaceuticals, inc. reports fiscal full year 2024 financial results and provides business update

Clinical and regulatory success in 2024 expected to drive value in 2025 cranford, n.j. , dec. 27, 2024 /prnewswire/ -- citius pharmaceuticals, inc. ("citius pharma" or the "company") (nasdaq: ctxr), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today reported business and financial results for the fiscal full year ended september 30, 2024.
CTXR Ratings Summary
CTXR Quant Ranking